|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Berdel, Andrew F.; Koch, Raphael; Gerss, Joachim; Hentrich, Marcus; Peceny, Rudolf; Bartscht, Tobias; Steffen, Bjoern; Bischoff, Marina; Spiekermann, Karsten; Angenendt, Linus; Mikesch, Jan-Henrik; Kewitz, Tobias; Butterfass-Bahloul, Trude; Serve, Hubert; Lenz, Georg; Berdel, Wolfgang E.; Krug, Utz und Schliemann, Christoph
(2022):
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy.
In: Annals of Hematology, Bd. 102, Nr. 1: S. 63-72
Floeth, Matthias; Elges, Sandra; Gerss, Joachim; Schwoeppe, Christian; Kessler, Torsten; Herold, Tobias; Wardelmann, Eva; Berdel, Wolfgang E.; Lenz, Georg; Mikesch, Jan-Henrik; Hartmann, Wolfgang; Schliemann, Christoph und Angenendt, Linus
(2020):
Low-density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia.
In: British Journal of Haematology, Bd. 192, Nr. 3: S. 494-503
Schliemann, Christoph; Gerwing, Mirjam; Heinzow, Hauke; Harrach, Saliha; Schwoeppe, Christian; Wildgruber, Moritz; Hansmeier, Anna A.; Angenendt, Linus; Berdel, Andrew F.; Stalmann, Ursula; Berning, Björna; Kratz-Albers, Karsten; Middelberg-Bisping, Kristina; Wiebe, Stefanie; Albring, Joern; Wilms, Christian; Hartmann, Wolfgang; Wardelmann, Eva; Kraehling, Tobias; Heindel, Walter; Gerss, Joachim; Bormann, Eike; Schmidt, Hartmut; Lenz, Georg; Kessler, Torsten; Mesters, Rolf M. und Berdel, Wolfgang E.
(2020):
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.
In: Cancers, Bd. 12, Nr. 6, 1488
Angenendt, Linus; Bormann, Eike; Pabst, Caroline; Alla, Vijay; Goerlich, Dennis; Braun, Leonie; Dohlich, Kim; Schwoeppe, Christian; Bohlander, Stefan K.; Arteaga, Maria Francisca; Wethmar, Klaus; Hartmann, Wolfgang; Angenendt, Adrian; Kessler, Torsten; Mesters, Rolf M.; Stelljes, Matthias; Rothenberg-Thurley, Maja; Spiekermann, Karsten; Hebert, Josee; Sauvageau, Guy; Valk, Peter J. M.; Loewenberg, Bob; Serve, Hubert; Müller-Tidow, Carsten; Lenz, Georg; Woermann, Bernhard J.; Sauerland, M. Christina; Hiddemann, Wolfgang; Berdel, Wolfgang E.; Krug, Utz; Metzeler, Klaus H.; Mikesch, Jan-Henrik; Herold, Tobias und Schliemann, Christoph
(2019):
The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.
In: Leukemia, Bd. 33, Nr. 12: S. 2830-2841
Oellerich, Thomas; Schneider, Constanze; Thomas, Dominique; Knecht, Kirsten M.; Buzovetsky, Olga; Kaderali, Lars; Schliemann, Christoph; Bohnenberger, Hanibal; Angenendt, Linus; Hartmann, Wolfgang; Wardelmann, Eva; Rothenburger, Tamara; Mohr, Sebastian; Scheich, Sebastian; Comoglio, Federico; Wilke, Anne; Stroebel, Philipp; Serve, Hubert; Michaelis, Martin; Ferreiros, Nerea; Geisslinger, Gerd; Xiong, Yong; Keppler, Oliver T. und Cinatl, Jindrich
(2019):
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.
In: Nature Communications, Bd. 10, 3475
[PDF, 2MB]